Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-30

Clinical Trial Update: A Phase I/II Trial to Preserve Residual Insulin Secretion in Children With Recent Onset Type 1 Diabetes by Giving Verapamil [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial is testing whether verapamil can preserve residual insulin secretion in children with recent-onset Type 1 diabetes; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Verapamil (verapamil)

Snippet

Sponsor: Johnny Ludvigsson | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: RECRUITING